30th Apr 2024 07:00                                
                                RNS Number : 4922M
 Cambridge Cognition Holdings PLC
 30 April 2024
  

 
30 April 2024
 
Cambridge Cognition Holdings plc
("Cambridge Cognition", the "Company" or the "Group")
 
Notice of Results
 
Cambridge Cognition Holdings plc (AIM: COG), which develops and markets digital solutions to assess brain health, will announce its Preliminary Results for the year ended 31 December 2023 on Wednesday 1 May 2024.
 
 
Enquiries:
 
| | Cambridge Cognition Holdings plc  Matthew Stork, Chief Executive Officer  Stephen Symonds, Chief Financial Officer  | Tel: 012 2381 0700    |  |   Panmure Gordon (UK) Limited (NOMAD and Joint Broker)  Freddy Crossley / Emma Earl   Rupert Dearden  |   Tel: 020 7886 2968  (Corporate Finance)  (Corporate Broking)  |  |   Dowgate Capital Limited (Joint Broker)  David Poutney / James Serjeant  |   Tel: 020 3903 7715    |  |   Hudson Sandler (Financial PR and IR)  Dan de Belder / Hattie Dreyfus  |   Tel: 020 7796 4133  [email protected]   | 
 | 
 | 
 
Notes to Editors
 
About Cambridge Cognition
 
Cambridge Cognition is a technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The Company's software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early and improve global efficiency in pharmaceutical and healthcare industries.
 
For further information visit: https://cambridgecognition.com/
 
 
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact 
[email protected] or visit 
www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our 
Privacy Policy.
 
 END
 
 
NORBIGDSUUDDGSC
                                
Related Shares:
Cambridge Cog